Monday, 23 January 2012
Business As Usual at the FDA
This story in the�Wall Street Journal�barely made a splash last week - "FDA Panelists Had Ties to Bayer." Three advisors who had financial ties to Bayer AG were invited to serve on a "safety committee" for the FDA to assess the safety of four Bayer AG birth control drugs. All three individuals were either paid [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment